Since its incorporation in March 2017, ARES has established an international team of highly committed business and technology experts with proven innovation & commercialization track-record.
Together, and supported by our global partner network, we are working towards revolutionizing infectious disease diagnostics and therapeutics.
- Theo deVosManaging Director & CEO
- Dr. Johannes WeinbergerManaging Director & CSO
- Faranak AtrzadehHead of Market Access USA